Last reviewed · How we verify
NCT04190407
Intravenous Access Time in Pediatric Patients
NA trial testing Intravenous access in Intravenous Access in 84 participants. Completed in 31 January 2018.
1 January 2018
Quick facts
| Lead sponsor | Istanbul Medeniyet University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 84 |
| Start date | 1 January 2017 |
| Primary completion | 1 January 2018 |
| Estimated completion | 31 January 2018 |
Drugs / interventions tested
- Intravenous access
Conditions studied
- Intravenous Access — all drugs for Intravenous Access →
- Pediatric Patient — all drugs for Pediatric Patient →
Sponsor
Istanbul Medeniyet University
Who can join
Adults 2 Months to 11, any sex, with Intravenous Access or Pediatric Patient. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In pediatric patients with no vascular access, anesthesia induction is usually achieved with sevoflurane. The aim of investigators to evaluate the optimum intravenous access time and the corresponding bispectral index (BIS) value in pediatric surgery under sevoflurane anesthesia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Investigation of the Optimum Time for Intravenous Access After Anesthesia Induction with Sevoflurane in Pediatric Patients Without Premedication.
Orhon ZN, Orhon C. · · 2020 · PMID 32733756 · DOI 10.5222/mmj.2020.22309
Verify or expand the search:
- PubMed search for NCT04190407
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intravenous access
Trials testing the same drug.
- NCT04366297 — Intravascular Access of COVID-19 Patient Under Personal Protective Equipment · NA · completed
Other Istanbul Medeniyet University trials
Trials by the same sponsor.
- NCT07478380 — Transcutaneous pO₂ Monitoring in PICU · recruiting
- NCT07368244 — Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Co · recruiting
- NCT07179731 — Comparison of the Effects of External Oblique Intercostal Plane Block, Subcostal Transverse Abdominis Plane Block, and T · NA · not yet recruiting
- NCT07241455 — Validity of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx-TR) in Turkish Pediatric Intensive Care · completed
- NCT07426497 — Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04190407 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Medeniyet University
- Last refreshed: 11 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04190407.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing